Media
Mediabyzbeats

ZBeats Awarded National Science Foundation (NSF) SBIR Phase I Grant to Advance Cloud-Based ECG Analysis Platform

Stony Brook, NY – September 15, 2020 — ZBeats INC, a digital health startup focused on scalable cardiac diagnostic software, has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). The award, totaling $256,000 under Award No. 2025951, supports ZBeats’ development of a cloudbased ECG analysis platform designed to improve the eRiciency and accessibility of longterm ambulatory cardiac monitoring.

The funded project centers on the creation of a machine-assisted ECG interpretation system that supports technicians and physicians in identifying arrhythmias more eRiciently and with greater clarity. The proposed solution includes rule-based and data-driven signal processing methods, complemented by annotation and review tools designed to enhance technician oversight and streamline the production of clinical reports.

“This NSF award reflects our commitment to building meaningful tools that support—not replace—clinical decision-making, By combining intelligent signal processing with workflow-focused tools, we hope to oRer providers new ways to manage long-duration ECG data with speed, accuracy, and transparency.”Dr. Bin Fang, CEO and Co-Founder

Exploring Anatomy & Physiology in the Lab

The ZBeats Phase I eRort focused on:

  • Developing rule-based and early-stage machine learning algorithms for beat detection and arrhythmia classification.
  • Evaluating performance of these algorithms using ANSI/AAMI EC57:2012 benchmarking standards.
  • Prototyping interactive annotation tools for use by cardiovascular technicians and clinicians.
  • Conducting early user evaluations with potential adopters to refine software usability and design.

The broader impact of this research lies in the potential to reduce delays and improve diagnostic yield in outpatient ECG monitoring, especially for patients at risk of arrhythmia related complications such as syncope, stroke, and sudden cardiac death. By oRering a vendor-neutral, cloud-based system that supports high-volume ECG review, ZBeats aims to help IDTFs, sleep labs, cardiology clinics, and remote patient monitoring (RPM) networks scale services while preserving the interpretive control of clinical teams. This award was made under the NSF’s rigorous review criteria, reflecting both the project’s technical merit and its potential for broader health and economic benefit.

Exploring Anatomy & Physiology in the Lab

ZBeats is a medical technology company focused on software innovation for ambulatory cardiac monitoring. Its platform integrates deterministic ECG analysis, techniciansupervised workflows, and hardware-agnostic compatibility to support scalable, cloudbased diagnostics.

Media
Mediabyzbeats

ZBeats Launches Feasibility Study of Cloud-Based ECG Diagnostic System for Long Term Monitoring

ZBeats Launches Feasibility Study of Cloud-Based ECG Diagnostic System for Long Term Monitoring

Most laboratory is a facility that provides controlled conditions in which scientific technological research, experiments, and measurement may be performed. Laboratories are found in a variety of privately owned research institutions, settings such as schools, universities, to research and testing facilities, government regulatory and forensic investigation centers, physicians offices.

The organization and contents of laboratories are determined by the differing requirements of the specialists working within. physic laboratory might contain a particle accelerator while a psychologist’s laboratory might be room with one-way mirror and hidden camera which to observe behavior. In some laboratories, such as those commonly used by computer scientists or vacuum chamber, while a metallurgy laboratory could a have apparatus for casting or refining metals or for testing their strength. A chemist or biologist might use a wet laboratory,

“Our goal is to close the diagnostic gap by making long-term ECG analysis more
accessible, eRicient, and clinically actionable,” said [insert responsible spokesperson].
“This study marks a critical step toward enabling more timely rhythm interpretation,
reduced costs, and expanded clinical use cases—especially in remote patient monitoring.”Founder and CEO

ZBeats’ prototype system, ZBPro™, has been validated against ANSI/AAMI EC57 benchmark datasets and internal test sets, showing high accuracy in arrhythmia detection using a rulebased engine. The feasibility study will gather data on operational performance, transmission reliability, and clinical integration over the course of real-world use.

With a vision of democratizing access to high-quality arrhythmia detection, ZBeats’ cloudbased model aims to reduce time-to-diagnosis from weeks to minutes, enhance
transparency for physicians, and support broad deployment across telehealth and outpatient care.

About ZBeats Inc.

ZBeats is a New York-based medical technology company developing cloud-based ECG software and wearable sensor integrations for ambulatory cardiac monitoring. The company’s mission is to bring scalable, clinician-centered solutions to healthcare systems, IDTFs, and digital health providers.

Media
Mediabyzbeats

ZBeats Selected by NIH to Exhibit Ambulatory Cardiac Monitoring Technology at VIVE Conference

ZBeats Selected by NIH to Exhibit Ambulatory Cardiac Monitoring Technology at VIVE Conference

Nashville, TN – March 26, 2023 — ZBeats, a digital health company advancing scalable solutions in cardiac diagnostics, is pleased to announce its selection by the National Institutes of Health (NIH) to exhibit at the VIVE Conference in Nashville, Tennessee. This sponsorship, extended through the NIH Small Business Innovation Research (SBIR) program, underscores ZBeats’ role in driving innovation in ambulatory ECG analysis and cloud-based diagnostic workflows.

At the conference, ZBeats will present its ZBPro Diagnostic software—an FDA-bound Software as a Medical Device (SaMD) designed to support technician-led ECG interpretation and report generation—as well as its early-stage wearable prototype, ZBPatch, developed to improve long-duration ECG recording for patients in outpatient and remote settings.

“We are proud to represent NIH-funded innovation at one of the industry’s leading health technology events,” said Dr. Bin Fang, CEO and Co-Founder of ZBeats. “This opportunity highlights our commitment to improving diagnostic eViciency and accessibility in cardiac care.”

 

Exhibit Highlights at VIVE 2023:

  • Technology Showcase: Live demonstrations of ZBPro Diagnostic and the betastage ZBPatch will highlight improvements in technician workflows, signal quality review, and scalable diagnostics.
  • SBIR-Driven Development: ZBeats will share outcomes from its NIH-funded research projects, including enhancements in ECG signal processing and long-wear
    device usability.
  • Interactive Engagement: Attendees can explore hands-on use cases and learn how ZBeats’ software platform integrates with electronic health record (EHR) systems and device data sources.
  • Partnership Opportunities: ZBeats welcomes engagement with clinics, IDTFs, research institutions, and digital health partners exploring advanced tools for ambulatory rhythm monitoring.

About ZBeats

ZBeats Inc. is a medical technology company focused on delivering software-driven solutions for ambulatory cardiac diagnostics. Its product suite spans Holter, extended Holter, and mobile cardiac telemetry use cases, with a focus on transparency, clinician oversight, and operational scalability. ZBeats is an NIH SBIR awardee and maintains development operations in New York.

About the NIH SBIR Program

The NIH Small Business Innovation Research (SBIR) program supports early-stage health and life sciences technologies with commercial potential. Its funding enables companies like ZBeats to bring high-impact innovations to market while advancing public health objectives.